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1. Introduction
Microbes have been characterized as planktonic, free-floating single cells. The morphological
and physiological properties of microbes have been described as they grow in nutritionally
rich culture media. Earlier very little thought have been given how microbes survive in the
environment. But, the fact is, in natural environment, microbes are commonly found to be
attached to surfaces as biofilms. Hence, the formation of surface attached microbial cells known
as biofilms open a new horizon to study the micro-organisms.
Automatically, the question arises, “What is biofilm?” According to the recent definition,
Biofilms can be defined as sessile communities of microbial cells irreversibly attached to a
surface or interface or to each other which are embedded in a self produced matrix of extrac‐
ellular polymeric biomolecules and are physiologically different from planktonic cells with
respect to growth rate and gene transcription [1]. While studying Pseudomonas aeruginosa
Davis and Geesay have shown that gene algC controlling phosphomannomutase involved in
alginate (exopolysacharide) synthesis is upregulated within 15 minutes of adhesion to a solid
surface [2].
Biofilms are ubiquitous. They can be present on any surface – biotic or abiotic. Biofilms can be
found on ship hulls, dairy and petroleum pipeline and rocks or pebbles at the bottom of streams
or rivers. They can grow in hot acidic pools in Yellowstone National Park (USA) and on glaciers
in Antarctica. Biofilms can form anywhere with easy access to water e.g. on tiles of floor,
kitchen platform or clogged sink etc. They are also found on plants and can remain symbiot‐
ically or cause crop diseases like citrus canker, Pierce’s disease of grapes etc [3]. Fossilised
bioilms with 3.5 billion years are among the oldest records of life on earth [4]. Biofilms are also
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associated with biocorrosion of metals(microbiologically influenced corrosion.i.e.MIC) which
affect kinetics of cathodic and or anodic reactions [5]. Biofilms can also grow in contact lenses,
biomedical implants and transcutaneous devices.
Nearly every species of microorganisms e.g. bacteria, fungi, algae and protozoa have mecha‐
nisms to adhere to surfaces and to each other. It has been found that over 90% of all bacteria
live in biofilms. Biofilms can be formed by single species of microorganism or by multiple
species of bacteria, fungi, protozoa etc. Mixed species biofilms predominate in environment.
Single species biofilm usually exist in a variety of infections and on medical implants and are
the focus of current research [6].
Study of biofilm began when it was discovered that in natural aquatic system bacteria
predominantly remain attached to surfaces [7]. The first recorded observation of biofilm was
presented by Henrici in 1933 as ‘it is quite evident that for the most part water bacteria are not
free floating organisms, but grow upon submerged surfaces’ [8]. The fouling of ship hulls by
microbes in marine environment was already known to mankind. Hence, the study of biofilm
has been started with marine bacteria, followed by fresh water microbial ecosystem and
formation of biofilm on surface of eukaryotic tissue.
In early part of 20th Century it was difficult to observe biofilm as electron microscopy required
complete dehydration of highly hydrated bioilm matrices and light microscopy was badly
distorted by out-of-focus effects [1]. Though Confocal Laser Scanning Microscope (CLSM) was
invented in 1950s it was never used to study bacteria. CLSM produces optical slices of complex
structures, so out of focus effects are removed and it requires no sample preparations, so living
microorganisms can be observed if fluorescent dye is introduced to observe the cells [1]. Hence,
the modern biofilm era began with the use of Confocal Laser Scanning Microscope (CLSM)
which showed the image of biofilm as sessile microbial cells embedded in matrix interspersed
between open water channels [9].
The development of biofilm is a 5 stage process – 1) reversible attachment 2) irreversible
attachment 3) early development 4) maturation 5) detachment or dispersal of cells. When the
microbial cell reaches very closer to a surface (<1nm), the initial attachment depends upon the
total attractive or repulsive forces between two surfaces. These forces include electrostatic and
hydrophobic interactions, steric hindrance, van der Waals forces etc. Probably hydrophobic
interactions play important role in primary adhesion [10]. The second stage of irreversible
attachment employs molecular binding between specific adhesins and the surfaces [11].
The factors controlling biofilm formation are: i) recognition of attachment sites on a surface ii)
nutritional cues iii) change of pH and temperature iv) exposure to antibiotics, chemical
biocides, and host defense mechanisms e.g. complement system etc.
The gene expression in biofilm cells differ from planktonic cells and by 2D gel electrophoresis
it had been found that in mature biofilm of Pseudomonas aeruginosa >300 proteins were
detectable that were undetectable in planktonic cells [12].
During colonisation, microbial cells communicate via quorum sensing. In mature biofilm
quorum sensing regulates formation of channels and pillar like structure for nutrient delivery.
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Microbial cells in biofilms undergo cell density-dependent gene regulation i.e. quorum sensing
and thus coordinate through signalling molecules called autoinducers. Autoinducers increase
in concentration as a function of cell density [13]. Usually Gram positive bacteria use processed
oligopeptides to communicate, where as Gram negative bacteria use N- acyl homoserine
lactones (AHLs) as autoinducers [14]. The widespread AI-2 quorum-sensing system is found
in several, Gram positive and Gram negative bacteria also [15]. For acyl-HSL quorum-sensing,
an enzyme belong to Lux I family is required for synthesis of signal from cellular metabolites
[16]. For AI-2 quorum-sensing system which has been implicated in interspecies communica‐
tion, the synthesis of signalling molecule is directed by the Lux S gene product [17]. The ahyR/
I acyl- HSL quorum sensing system of Aeromonas hydrophila has been shown to be required
for biofilm maturation [12]. Similarly the Lux S type quorum sensing system in Streptococcus
mutants is also involved in biofilm development. Lux S system of Salmonella enterica serovar
Typhimurium is required for biofilm formation on human gallstones [18].
Duenne described biofilm architecture as underwater coral reef with pyramid or mushroom
shaped projections from the surface and channels and caverns running through out [19]. Using
CLSM, Lawrence et al has shown that Pseudomonas biofilms were more tightly packed at the
surface and less dense near the periphery whereas Vibrio parahaemolyticus biofilms show
greatest cell density near the periphery [20].
The adherent cells in a biofilm are embedded with a self produced matrix of extracellular
polymeric biomolecules. 97% of a biofilm matrix is water. A complex of secreted polymers,
absorbed nutrients and metabolites, cell lysis product and even particulate materials from the
surrounding environment can form matrix. Actually the matrix surrounds, anchors and
protects surface-bound microbes. The matrix actually prevent the access of antimicrobials and
disinfectants and confer protection against environmental stresses such as UV radiation, pH
shifts, osmotic shock and dessication [21].
Besides microbial cells all major classes of macromolecules i.e. proteins, polysaccharides,
nucleic acids can be observed within a biofilm. Even transformation, transduction and
conjugation result in gene transfer amongst the cells in biofilm.
Biofilms are formed by many bacterial species of medical importance e.g. Staphylococcus
epidermidis, Staphylococcus aureus, Enterococci, Streptococcus mutans, Pseudomonas aeruginosa,
E.coli O157:H7, Neisseria gonorrhoeae, Vibrio cholerae, Nontuberculous mycobacteria (NTM) etc [6].
Amongst fungi - Candida albicans can usually form biofilm [22]. The two most intensely
studied biofilms are produced by: Staphylococcus epidermidis and Pseudomonas aeruginosa.
1.1. Biofilms and human disease
The microbial biofilm has received much attention recently because biofilm mode of growth
may be the key factor in persistent or chronic infections. The biofilms can act as nidus of acute
infections and the microbial cells from biofilm are released at any one time during chronic
infection [23]. Clinicians are very much concerned about the fact that it is really difficult to
eradicate biofilm bacteria with antibiotics. Even in immunocompetent host the biofilm growth
are rarely resolved by host’s immune system as antigen may be hidden and key ligands may
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be repressed [24]. Biofilms are associated with kidney stones of infective origin, formation of
dental plaques, infections in cystic fibrosis, infections of permanent indwelling devices such
as joint prosthesis & heart valves, intrauterine devices (IUDs) and urinary catheters etc [25].
However in many chronic infections both the biofilm and planktonic growth may coexist.
Parsek and Singh in 2003 have proposed few criteria to define the role of biofilms in human
diseases [12]: a) the causative bacteria are surface associated b) examination of infected tissue
shows bacteria living in microcolonies and embedded in extracellular matrix c) infection is
usually confined to a particular site and dissemination occurs as a secondary phenomenon d)
the infection is difficult to eradicate with antibiotics though the causative bacteria are suscep‐
tible to that antibiotics in planktonic state.
1.1.1. Infection-related kidney stones
15-20% of kidney stones occur in the setting of urinary tract infections. Infact, infection stones
are produced by interplay between infecting bacteria and mineral substrates derived from
urine resulting in formation of a complex biofilm. Microscopic analysis of stone has revealed
that bacteria are organized in microcolonies and surrounded by an anionic matrix composed
of both polysaccharides and crystallized minerals [26]. It requires an alkaline environment to
decrease solubility of phosphate, increased concentration of NH4+ for struvite and CO3- for
carbon apatite formation as these are major constituents of this type of stone. The normal urine
is not saturated with struvite and carbon apatite. The alkaline pH of urine occurs in infection
with urease producing organisms like Proteus, Providencia, Klebsiella and Pseudomonas species.
It is hypothesized that biofilms provide localized and concentrated urease activity to form
stones [26].
1.1.2. Bacterial endocarditis
The primary lesion in endocarditis is due to vegetation (valve biofilm), which is composed
mainly of bacteria and their products, platelets and fibrin derived from circulation with the
damaged endothelial surface as substratum. Durack in1975, developed nonbacterial throm‐
botic endocarditis by leaving a polyethylene catheter in contact with aortic valve of a rabbit
and showed how bacterial microcolonies were formed within 24 hours [27].
1.1.3. Airway infections in cystic fibrosis
Cystic  fibrosis  (CF),  a  common inherited disease of  lower respiratory tract  is  caused by
mutation  in  the  gene  which  encodes  Cystic  fibrosis  transmembrane  regulator  protein
(CFTR).  CFTR functions  as  a  chloride  ion channel  protein  [1].  Chloride ion transport  is
severely impaired when CFTR is defective in CF patients, resulting in hyperviscous mucus.
Initially  CF  patients  suffer  from  intermittent  respiratory  infections  but  in  late  stage
permanent  infection with  P.  aeruginosa  occurs.  It  has  been found that  even with  higher
antibiotics  given  parenterally  P.  aeruginosa  could  not  be  eradicated  from sputum of  CF
patients in the late stage and it may persist for the rest of the patient’s life. In permanent
infection phase  of  CF patients,  P.  aeruginosa  biofilm may be  found in  airways.  Another
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interesting finding is emergence of P. aeruginosa with mucoid phenotype in late stage CF
patients [28]. This mucoid material is a polysaccharide i.e. alginate which probably prevent
antibody  coating  and  opsonic  phagocytosis.  In  fact,  biofilm  protects  P.  aeruginosa  from
antimicrobials  and host  defenses.  Genetic  fingerprinting  studies  show same strain  of  P.
aeruginosa can persist in CF patients for decades leading to chronic inflammation and decline
in lung function and ultimately respiratory failure [29].
1.1.4. Endodontics
Biofilms also play a major role in causing dental caries, gingivitis, periodontitis, apical
periodontitis etc [30].The anatomical complexities in root canal system provide favourable
condition for biofilm formation, which is actually initiated by invasion of pulp chamber by
oral flora after tissue breakdown. Facultative or strict anaerobes are more frequently associated
than aerobic microorganisms. Porphyromonas gingivalis is the primary agent responsible for
periodontitis [31]. Endodontic biofilm can be—i) intracanal, ii) extraradicular, iii) periapical
and iv) foreign body centered. Foreign body centered biofilm is a major complication associ‐
ated with prosthesis and implant supported prosthesis [32].
1.1.5. other conditions
Similarly during acute phase of osteomyelitis, microscopical examination have shown biofilm
formation on infected bone surfaces [33]. In chronic prostatitis, adherent bacterial colonies on
the surface of prostatic duct have been observed on microscopical studies, even in culture
negative cases [34].
1.1.6. Indwelling medical devices
Biofilms can develop on indwelling medical devices like prosthetic heart valve, pacemakers,
central venous catheter, urinary catheter, contact lenses, intrauterine devices etc. and can cause
persistent infections which are usually lethal. Scanning electron microscopy clearly shows
biofilm formation at the tip of urinary catheter kept for 7 days. On medical devices, biofilms
are most commonly formed by coagulase negative Staphylococci (CoNS) especially S. epider‐
midis followed by S. aureus, Enterococci, Pseudomonas aeruginosa etc.
Biofilms can develop on both types of contact lenses i.e. soft and hard and also on contact lens
storage cases. Pseudomonas aeruginosa, Staphylococcus aureus, Staphylococcus epidermidis, E.coli,
Candida species can adhere to contact lenses [35]. Evidence of biofilm on contact lenses and
it’s storage cases have been reported from patients with microbial kerattis [36]. The rate of
prosthetic valve endocarditis (PVE) range from 0.5% to 4% [37]. Coagulase negative Staphy‐
lococci are the commonest early colonizers after surgical implantation of prosthetic valve
whereas Streptococcus viridans most commonly colonize during late PVE (i.e. 12 months
following valve replacement) [38]. Though S. aureus, Gram negative coccobacilli or fungi may
also be responsible for PVE.
Infection with central venous catheter is a quite common device related infection. Biofilms
have been shown by CLSM to be present outside the catheter or inner lumen [34].
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In S. epidermidis biofilm initial adherence is by polysaccharide adhesin (PSA) and accumulation
of cells is due to production of polysaccharide intercellular adhesin (PIA).) PIA is encoded by
ica (intercellular adhesin) operon ica ADBC [39]. The icaR gene regulates ica operon. Production
of PIA is also subject to ON - OFF switching (phase variation). Majority of clinical isolates of
S. aureus also possess ica structural genes [40].
1.1.7. Health care Associated Infections (HAI) and biofilm
Catheter Associated Urinary Tract Infection( CA-UTI) is the commonest (>40%) HAI [41].
Nosocomial bacteriuria or candiduria develops in 25% of patients having urinary catheter for
>7 days with a daily risk of 5% [42]. Most infected urinary catheters are covered by a thick
biofilm containing infecting microorganisms. A biofilm forms intraluminally or extraluminally
or both ways.
With the increasing use of vascular access devices, catheter related bloodstream infection (CR-
BSI), septic thrombophlebitis, endocarditis and other metastatic infections e.g.lung abscess
osteomyelitis and endophthalmitis etc. are also increasing. In the United States out of 5 million
Central Venous cathetes used each year, 3-8% lead to BSI [43]. The initiation of catheter
colonization occurs with the formation of a biofilm in the catheter lumen. Moreove the
resistance levels of biofilm associated organisms may be much higher than those of planktonic
organisms [44]. After stoppage of antimicrobial therapy, the biofilm associated organisms
resurge and cause another clinical infectios. A recent approach to reduce CR-BSI is bundles of
preventive measures, which means a group of preventive measures, when executed together,
result in better outcomes than when implemented alone [45]. This included handwashing,
using full barrier precautions during insertion of central venous line, cleaning the skin with
chlorhexidine. The femoral site should be avoided if possible and catheters should be removed
as early as possible.
Hospital acquired pnumoniais are the second most common cause of HAI and has the highest
morbidity and mortality of all HAIs [46]. The initial step in pathogenesis of HAP is colonization
of patient’s oropharynx with resistant hospital pathogen. The endotracheal tube lumen is a
nidus for the growth of bacteria within the biofilm. Hand washing and Personal protective
equipment (PPE) must be used to reduce the incidence of HAP/ Ventilator assaociated
pneumonia (VAP).
1.1.8. Resistance of biofilm to antimicrobials and disinfectants
It has been observed that biofilms are not easily eradicated even by cidal antimicrobials,
quarternary ammonium compounds, halogens and halogen release agents. The crux of the
problem is the presence of persisters within the biofilms that can rebound when antibiotic
concentration falls. The causes are multifactorial – i) restricted penetration of antimicrobials
within the biofilm architecture, ii) decreased growth rate of bacterial cells forming the biofilm,
iii) expression of resistance gene by the bacterial cells within the biofilm etc [47]. Restricted
penetration of antimicrobials may occur as negatively charged exopolysaccharide restrict
permeation of positively charged antibiotics e.g. Aminoglycoside and exopolymer matrix also
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restrict diffusion of antimicrobial within the biofilm. Synergy between retarded diffusion and
degradation by enzymes (e.g. β-lactamase) also provide effective resistance to antimicrobials.
Fluoroquinolones are very effective in stopping the growth of a biofilm but restricted diffusion
can protect the microbial cells within the biofilm [48]. All antimicrobials are more effective in
killing rapidly growing cells. Penicillin & ampicillin do not kill non-growing cells as rate of
killing is directly proportional to rate of growth for these two antibiotics. Even cephalosporins,
aminoglycosides & fluroquinolones can kill rapidly dividing cells more effectively. Multiple
drug resistance (MDR) pumps may play a role in biofilm resistance at low antibiotic concen‐
tration. Sometimes unknown MDR pumps might be over expressed in biofilm e.g. for chlor‐
amphenicol in E. coli biofilm. Moreover, the biofilms increase the opportunity of gene transfer
beteen the microorganisms and can convert a previously avirulent commensal organism to a
highly virulent pathogen. The enhanced efficiency of gene transfer in biofilms also fascilitates
the spread of antibiotic resistance and virulence factors [49]. Though most of the research
works deals with single species biofilms, multispecies biofilm amongst different bacteria and
interkingdom biofilms between fungus Candida albicans and various bacterial species are also
gaining importance in causing different diseases [50]. Biofilm formation is a major virulence
factor for Candida albicans and Candida biofilms are difficult to eradicate due to their high
resistance to antifungals. A recent study has reported that within the biofilm Staphylococcus
aureus was attached uniquely with the pseudohyphae of Candida albicans. This synergistic
interaction resulted in differential protein expressions which are actually virulence factors for
Staphylcoccus aureus. This indicate C. albicans may enhance S.aureus pathogenesis [51].
Recently it has been reported that co-existence of S.aureus and C.albicans in a biofilm resulted
in increased Vancomycin resistance in S.aureus [52] However antagonistic interaction has been
reported between Pseudomonas aeruginosa and Candida albicans [53].
It is not possible to detect the antimicrobial resistance of biofilms by conventional methods of
disc diffusion and broth microdilution as per CLSI guideline because these methods are only
meant for planktonic cells.
1.1.9. Biofilms and altruism
Biofilms are like small cities and encourage altruism. Microbial cells within biofilm often
sacrifice their maximum growth rate to use the available community resources more efficient‐
ly. In a biofilm atleast some of the microbial cells experience nutrient limitation and exist in a
slow growing state [54]. In this process while individual cells are disadvantaged, the microbial
community as a whole is benefited. Hence, it is said that biofilms are the colonial way of life
of microorganisms.
Detection of biofilms can be done by both phenotypic methods and genotypic methods. In
phenotypic methods biofilms are detected by Congo red agar method(CRA),Plastic tube
method(TM), Tissue culture plate method(TCP) and Confocal Laser Scanning Microscopy
(CLSM). In genotypic method, usually Polymerase chain reaction (PCR) for amplification of
microbial DNA, coding for biofilm formation is done. The phenotypic methods are easy and
cheap compared to genotypic method.
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Hence, the present study was undertaken to detect the biofilm producing organisms, isolated
from different clinical specimens in our laboratory.
2. Material and methods
The present study was conducted from 2009 to 2012. A total number of 350 bacterial and 50
Candida strains were studied. The microbial strains were isolated from different clinical
specimens like urine, blood, pus and wound swab, endotracheal aspirate, urinary catheter tip,
central venous catheter tip etc. All the microbial strains were identified by conventional
methods [55]. We used microtitre plate biofilm assay to detect microbial attachment to an
abiotic surface [56].
Steps:
1. The microbial cells were grown in Brain heart infusion broth overnight.
2. On next day, the cultures were diluted 1:100 using the brain heart infusion broth.
3. 100µl of each diluted culture was inoculated into each of three wells in a microtiter plate
which has not been tissue culture treated. The plates were covered by the lid and was
incubated at optimal growth temperature [56] for 48 hours
4. Then the wells were washed twice to remove planktonic cells.
5. Microbial cells which were adhered to the wells were subsequently stained with crystal
violet solution that allowed visulisation of the attachment pattern. 125 µl of 0.1% crystal
violet solution was added to each well and stained for 10 minutes at room temperature.
6. The microtiter plates were shaken and the crystal violet solution was removed.
7. The plates were washed successively twice with distilled water. Any crystal violet that is
not specifically staining the adherent microbial cells were removed by this washing step.
8. The microtiter plates were then inverted and tapped vigorously on tissue paper to remove
any excess liquid.
9. The microtiter plates were then air dried. The dried microtiter plates may be stored at
room temperature for several weeks.
10. This surface associated dye was solubilized by adding ethanol or any other solvent for
semiquantitative assessment of biofim formed. 200µl of 95% ethanol or other appropriate
solvent [56] was then added to each stained well and was kept for 10 to 15 minutes
11. The contents of each well were mixed by pipetting and then 125µl of the crystal violet /
ethanol solution from each well was transferred to a separate well of another 96 well
microtiter plate maintaining the same sequence.
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12. Then the optical density of each well containing 125µl solution was measured at a
wavelength of 545nm in an ELISA reader. As each strain was put in triplicate the average
of the three readings were taken.
The biofilm formation of different strains were classified in three groups according to the cut
off OD. The cut off OD (ODc) for the microtiter plate test was defined as three standard
deviations above the mean OD of the negative control. Isolates were classified into four groups
as nonadheremt, weakly adherent, moderately adherent and strongly adherent according to
Stepanovi et al [57].
3. Observation and results
Out of 350 bacterial strains studied, 90 were Pseudomonas aeuginosa, 80 were E. coli, 35 were
Klebsiella pneumoniae, 80 were Coagulase positive Staphylococci, 30 were Coagulase negative 35
included Proteus sp(5), Vibrio cholerae(3), Acinetobacter baumanii(4), Enterococcus sp.(23). Out
of 50 Candida strains 23 were Candida albicans, 16 were Candida tropicalis, 2 were Candida
dubliensis, 6 were Candida krusei and 3 were Candida glabrata. Amongst 350 bacterial strains,
153(43.7%) and out of 50 Candida species 28(56%) were biofilm producers respectively.
Amongst 50 Candida species, 11 (22%) were strong biofilm producers, and 6/11 (54.5%) were
Candida albicans.
Figure 1. Microtitre plate biofilm assay for detection of microbial attachment
Maximum 65( 72.2%) of Pseudomonas aeruginosa strains produced biofilms. 51(33.3% ) biofilm
producing bacterial strains were isolated from catheterized urine samples or patients having
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other medical devices. 108(70.6% ) bacterial strains producing biofilms were isolated from
patients having chronic infections eg persistent or recurrent UTI, Chronic obstructive airway
disease, cystic fibrosis etc.
In our study the cut off OD(ODc) was 0.003. The biofilm forming organisms are grouped
into weak group (OD ≥ 0.003 to 0.006), moderate group (OD ≥ 0.006 to 0.012) and strong
group (OD > 0.012).
Newer β – lactamases producers Non β –
lactamase
producersOrganisms
ESBL
Only
AmpC
Only
MBL
Only
ESBL +
AmpC
ESBL +
MBL
AmpC
+ MBL
ESBL + AmpC
+MBL
P.aeruginosa [90] 10 14 10 23 - - - 33
Strongly adherent
biofilm producing
P.aeruginosa
7 6 4 11 - - - 5
E.coli [80] 10 7 4 38 1 - 1 19
Strongly adherent
biofilm producing
E.coli
6 4 2 20 1 - - 1
Klebsiella
pneumonia [35] 3 2 1 8 2 - - 19
Strongly adherent
biofilm producing
K. pneumoniae
1 1 1 4 1 - - 2
Proteus species [5] 3 1 - 1 - - - -
Strongly adherent
biofilm producing
Proteus species
1 - - - - - - -
Acinetobacter
baumani [4] 1 1 2 - - - - -
Strongly adherent
biofilm producing
Acinetobacter
baumani
- - 2 - - - - -
Table 1. Incidence of strong biofilm producers amongst newer β – lactamases producing strains
It was observed that out of 57 newer β – lactamases (Extended spectrum β – lactamases i.e.
ESBL, Amp C β – lactamases and Metallobetalactamases i.e. MBL only and in combination)
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producing Pseudomonas aeruginosa 28 (49.1%) were strongly adherent biofilm producers,
compared to only 5/33 (15.1%) non β – lactamase producers. Amongst the 120 Enterobacter‐
iaceae strains studied. 82 (68.3%) were newer β – lactamases producers, whereas 48/82 (58.5%)
were strong biofilm producers and only 3/38 (7.9%) non β – lactamase producing strains were
strong biofilm producers.
Organisms Methicillin resistant Methicillin sensitive
Coagulase positive Staphylococcus [80] 34 46
Strongly adherent biofilm producing
Coagulase positive Staphylococcus 14 2
Coagulase negative Staphylococci
(CONS) [30] 11 19
Strongly adherent biofilm producing
Coagulase negative Staphylococci
(CONS)
4 2
Table 2. Incidence of strong biofilm producing Methicillin resistant Staphylococcus strains.
Table 2 shows amongst the Methicillin Resistant Staphylococcus aureus (MRSA) strains, 14/34
(41.2%) and Methicillin Resistant Coagulase negative Staphylococci (MR – CONS) 4/11 (36.4%)
were strong biofilm producers compared to 2/46 (4.3%) Methicillin sensitive Staphylococcus
aureus (MSSA) and 2/19 (10.5%) Methicillin sensitive CONS.
Out of 23 Enterococcus species 13/23 (56.5%)were High level Aminoglycoside Resistant
(HLAR) strains and it was also found that 8/13 (61.5%) HLAR strains were strong biofilm
producers compared to only 2/10 (20%) of non HLAR strains.
4. Discussion
Our Hospital is a tertiary care centre in a rural setup. Though CLSM is the best phenotypic
method, it could not be used as it is very costly. We did a pilot study with Staphylococci in
2008 and found 33% of Staphylococcus aureus and 44.7% of Coagulase Negative Staphylococci
(CONS) were biofilm producers and amongst the 3 phenotypic methods tissue culture plate
method gave the best results [58]. The present study correlated well with reports of other
authors that Extended Spectrum β-Lactamase (ESBL) producing strains, Methicillin Resistant
Staphylococcs aureus(MRSA) were more adherent to microtitre plate than Non ESBL and Non
MRSA strains (Figure 2).
Lee et al in 2008 have also reported a positive correlation between biofilm formation and ESBL
producing Acinetobacter baumanii [59]. Norouzi et al in 2010 have reported that in their study
14% ESBL producing Pseudomonas aeruginosa has formed strongly adherent biofilm com‐
pared to only 4% of non-ESBL producing Pseudomonas aeruginosa [60]. It has also been
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reported that, biofilm production was higher amongst MRSA strains as compared to Metthi‐
cillin sensitive S.aureus (MSSA) strains [61].
5. Treatment and control strategies
As far as the treatment of the persistant infection with medical device is concerned, the first
step is to remove the infected indwelling medical device. Several control strategies have been
proposed for biofilms e.g. systemic ciprofloxacin therapy in catheterized patients [1], latex
catheter coated with silicone or silver hydrogel, catheter containing or use of antibiotics
specially combination of Rifampicin and Minocyclin into material of indwelling catheters [62],
Nitrofurazon coating, pretreatment of catheter surfaces with Furanones or Liposomes,
Targetting the irradication of extra cellular polymeric biomolecules by enzymes [63] etc. Other
strategies include disinfection of the insertion sites [64], surgical site irrigation, with biocides
or antimicrobial locks to reduce indwelling catheter associated infections [65]. Cartin and
Donlan have reported the ability of bacteriophage to degrade biofilm formation by Staphylo‐
coccus epidermidis [66]. Vejborg and Klemn have reported blocking of bacterial biofilm
formation by a fish protein coating [67]. In dentistry, other than sodium hypochlorite irrigation,
the newer techniques for biofilm eradication include ultrasonic irrigation, Ozone, plasma
dental probe, photoactive disinfection with low energy LASER etc [32].
Figure 2. Strogly adherent biofilm producing strains (%) amongst newer β – lactamase producers and non β – lacta‐
mase producers
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To prevent biofilm formation, the physical approaches like the use of low strength electrical
field [68], electromagnetic field or ultrasound along with antibiotic therapy [69] are also very
promising. A novel treatment based on disruption of quorum sensing system to inhibit biofilm
formation has also been suggested by many workers [70]. Even the workers have suggested
the inhibition of transcription of genes that are activated or repressed during initial biofilm
formation will also help to prevent persistent infection due to biofilms. All these control
strategies are on experimental basis and are not applicable for medical devices and have their
own limitations to be used cuurently in patients.
To conclude, we must say biofilm develops slowly but has a major impact both clinically and
economically on overall outcome of the patients treatment. The authors feel that, EARLY
DETECTION AND NEWER TREATMENT OPTIONS FOR BIOFILM ASSOCIATED INFEC‐
TIONS ARE NEED OF THE HOUR.
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